Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials
Clinical trial NCT06548139 · UNKNOWN
Trial details
- NCT number
- NCT06548139
- Sponsor
- Changchun BCHT Biotechnology Co.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2025-05-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.